ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer

Liu, Chao; Xiao, Huiting; Cui, Luying; Fang, Lin; Han, Shuling; Ruan, Yuli; Zhao, Wenyuan*; Zhang, Yanqiao*哈尔滨医科大学
Frontiers in Immunology2022-11-21DOI: 10.3389/fimmu.2022.1039631
3阅读
引用收藏
分享

摘要

BackgroundCombination therapy with immune checkpoint inhibitors (ICIs) may benefit approximately 10-20% of microsatellite-stable colorectal cancer (MSS-CRC) patients. However, there is a lack of optimal biomarkers. This study aims to understand the predictive value of epigenetic-related gene mutations in ICIs therapy in MSS-CRC patients. MethodsWe analyzed DNA sequences and gene expression profiles from The Cancer Genome Atlas (TCGA) to examine their immunological features. The Harbin Medical University Cancer Hospital (HMUCH) clinical cohort of MSS-CRC patients was used to validate the efficacy of ICIs in patients with epigenetic-related gene mutations (Epigenetic_Mut). ResultsIn TCGA, 18.35% of MSS-CRC patients (78/425) had epigenetic-related gene mutations. The Epigenetic_Mut group had a higher tumor mutation burden (TMB) and frameshift mutation (FS_mut) rates. In all MSS-CRC samples, Epigenetic_Mut was elevated in the immune subtype (CMS1) and had a strong correlation with immunological features. Epigenetic_Mut was also associated with favorable clinical outcomes in MSS-CRC patients receiving anti-PD-1-based therapy from the HMUCH cohort. Using immunohistochemistry and flow cytometry, we demonstrated that Epigenetic_Mut samples were associated with increased anti-tumor immune cells both in tumor tissues and peripheral blood. ConclusionMSS-CRC patients with epigenetic regulation impairment exhibit an immunologically active environment and may be more susceptible to treatment strategies based on ICIs.

学科与关键词

关键词
immune checkpoint inhibitor therapybiomarkermicrosatellite-stablecolorectal cancerepigenetic-related gene mutations
相关
加载中…
  • DNA methylation-based patterns for early diagnostic prediction and prognostic evaluation in colorectal cancer patients with high tumor mutation burden
    Huang, Hao; Cao, Weifan; Long, Zhiping; Kuang, Lei; Li, Xi; Feng, Yifei; Wu, Yuying; Zhao, Yang; Chen, Yinggang; Sun, Peng; Peng, Panxin; Zhang, Jinli; Yuan, Lijun; Li, Tianze; Hu, Huifang; Li, Gairui; Yang, Longkun; Zhang, Xing; Hu, Fulan*; Sun, Xizhuo*; Hu, Dongsheng*Frontiers in Oncology, 2023, 12: 1030335.被引 2
  • Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer
    Lin, Anqi; Yao, Jiarong; Cheng, Quan; Liu, Zaoqu; Luo, Peng*; Zhang, Jian*Journal of Inflammation Research, 2023, 16: 1693-1709.被引 1
  • Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer
    Du, Fenqi; Liu, Yanlong*Journal of Clinical Laboratory Analysis, 2022, 36(1): e24141.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-11-21
卷期
第 13 卷
页码
1039631
DOI
10.3389/fimmu.2022.1039631
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82102858]; Natural Science Funding of Heilongjiang [YQ2022H017]; Excellent Discipline Construction Program; Basic scientific research projects of universities in Heilongjiang Province [2020-KYYWF-1465]; Top Young Talents Project of HMUCH [BJQN2021-01]; Haiyan Research Fund of Harbin Medical University Cancer Hospital [JJMS2022-04]; Beijing Science and Technology Innovation Medical Development Foundation [KC2021-JX-0186-102, KC2021-JX-0186-69]

作者

  • L

    Liu, Chao (第一作者)

    harbin med univ

  • X

    Xiao, Huiting

    harbin med univ

查看全部 8 位作者收起作者
  • C

    Cui, Luying

    harbin med univ

  • F

    Fang, Lin

    harbin med univ

  • H

    Han, Shuling

    harbin med univ

  • R

    Ruan, Yuli

    harbin med univ

  • Z

    Zhao, Wenyuan (通讯)

    harbin med univ

  • Z

    Zhang, Yanqiao (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417